Abhrak Bhasma: The Calcined Mica Formulation of Ayurveda

Abhrak Bhasma, the incinerated ash of mica, occupies a position of extraordinary significance in Rasa Shastra, the alchemical branch of Ayurveda dedicated to metals and minerals. Mica, known as Abhraka, is regarded as one of the most important mineral drugs, second only to mercury (Parada) in its therapeutic potential . The classical texts consider it the essence of the earth, possessing profound Rasayana (rejuvenative) properties that can restore vitality, enhance immunity, and promote longevity.

The transformation of raw mica into Bhasma is one of the most sophisticated pharmaceutical achievements of Ayurveda, requiring elaborate processing to render the biologically inert mineral into a safe, bioavailable, and therapeutically potent nanomedicine . Raw, unprocessed mica is considered Ashuddha (impure) and its internal use can lead to various disorders including Kshaya (wasting), Kustha (skin diseases), Karshya (emaciation), Pandu (anemia), Shotha (edema), and cardiac ailments . The rigorous processes of Shodhana (purification), Marana (incineration), and Amritikarana (detoxification) eliminate these risks while conferring therapeutic efficacy.

The therapeutic scope of Abhrak Bhasma is exceptionally broad, extending across internal medicine, neurology, endocrinology, and oncology. Its primary therapeutic intentions are:

· To function as a potent Rasayana (rejuvenative), promoting longevity, tissue regeneration, and immunity

· To act as a Medhya (nootropic), enhancing intellect, memory, and cognitive function

· To serve as a Balya (strengthening) agent, improving overall physical strength and vitality

· To pacify all three doshas (Tridoshahara), particularly Vata and Kapha

· To treat chronic and severe conditions including respiratory disorders, diabetes, anemia, and liver diseases

· To support tissue nourishment (Dhatu Pushtikara) and restore Ojas (vital essence)

· To function as an adjunctive therapy in cancer management through immunomodulation and cytotoxicity

2. The Source Material: Abhraka (Mica)

2.1 Classical Significance

Abhraka is described in Ayurvedic texts as one of the Maharasa (great minerals), a category of the most important mineral drugs. It is believed that Abhraka was the essence or Raja (excellence) of the earth goddess . Its significance is such that a unique procedure called Dhanyabhraka is prescribed exclusively for mica in the entire Rasa Shastra corpus . The classical texts emphasize that the therapeutic value of Abhraka Bhasma increases with the number of Puta (incinerations) it undergoes, with some preparations subjected to up to one thousand incinerations .

2.2 Occurrence and Types

Abhraka is a rock-forming mineral with highly perfect cleavage, belonging to the silicate group. It is found in various regions of India including Hazaribagh and Giridih in Bihar, Raniganj in Bengal, Nilgiris in Madras, Dharwar in Karnataka, and Nurpur in Kangra district of Punjab. It is also found in Brazil, Russia, Argentina, Canada, Peru, and Bolivia .

Classical Classification of Abhraka

Classical texts describe four primary types of Abhraka, each with distinct therapeutic applications:

Type 1: Pinaka Abhraka

· Description: A specific variety with distinct characteristics

Type 2: Naga Abhraka

· Description: Another classical variety

Type 3: Mandooka Abhraka

· Description: A third classical variety

Type 4: Vajra Abhraka

· Description: The black variety, considered the most important therapeutically

· Significance: This is the Krishna Vajra Abhraka acclaimed for its Rasayana quality . It is believed to contain more iron and is therefore better digested and assimilated

Sub-varieties Based on Colour

Each of the four primary types is further classified into four sub-varieties based on colour:

· Shweta (White): Used in preparing silver

· Peeta (Yellow): Used in preparing gold

· Rakta (Red): Used for purifying Hingula (cinnabar) and improving blood

· Krishna (Black): The most praised for its Rasayana quality

2.3 Mineralogical Classification

From a mineralogical perspective, mica is an aluminosilicate mineral that can be split into thin sheets or laminae. The major types include:

· Muscovite (Potash Mica): Colourless and transparent, of significant industrial importance

· Phlogopite (Magnesium Mica): Pale yellow or blackish brown, known as Amber Mica

· Biotite (Magnesium Iron Mica): Black in colour, corresponding to Krishna Vajra Abhraka

· Paragonite (Sodium Mica)

· Lepidolite (Lithia Mica)

· Zinnwaldite (Lithium Iron Mica)

· Lepidomelane (Iron Mica)

2.4 Chemical Composition

The chemical composition of Abhraka varies depending on its source and variety. Analysis of mica obtained from Bihar reveals the following composition :

· Silica (SiO₂): 45.57%

· Alumina (Al₂O₃): 36.72%

· Ferric Oxide (Fe₂O₃): 0.95%

· Ferrous Oxide (FeO): 1.28%

· Magnesia (MgO): 0.38%

· Lime (CaO): 0.21%

· Potash (K₂O): 8.81%

· Soda (Na₂O): 0.62%

· Lithia (Li₂O): 0.19%

· Water (H₂O): 5.05%

· Fluorine (F): 0.19%

3. Preparation Protocol

The preparation of Abhrak Bhasma is a multi-stage process involving Shodhana (purification), Dhanyabhraka (grain treatment), Marana (incineration), Amritikarana (detoxification), and Lohitikarana (colour conversion) . Each stage is designed to progressively refine the material and enhance its therapeutic properties.

3.1 Shodhana (Purification)

Principle: Nirvapa (heating and quenching) in Triphala Kwatha (decoction of three myrobalans) for seven times.

Procedure :

· Initial Material: 1000 g of Krishna Vajra Abhraka (black mica)

· Media Used: Triphala Kwatha (decoction prepared from Amalaki, Haritaki, and Vibhitaki)

· Process: The raw mica is cleaned, air-dried, heated until red-hot using a fire gun or traditional method, and then quenched in Triphala Kwatha

· Collection: The quenched Abhraka is collected, stirred into finer particles, and sun-dried

· Repetition: This Nirvapa process is repeated for a total of seven cycles

Observations During Shodhana :

The mica undergoes progressive transformation through each Nirvapa:

· Initially: Black, solid mass

· 1st Nirvapa: Shiny black, pieces softened, layers separated

· 2nd Nirvapa: Shiny black, small pieces and chunks present

· 3rd Nirvapa: Shiny black with golden sheen, semi-powder form with small chunks

· 4th Nirvapa: Shiny black with golden lustre, powder form with fine dispersed particles

· 5th Nirvapa: Black with stronger golden lustre, fine dispersed particles

· 6th Nirvapa: Bright golden lustre, fine dispersed particles

· 7th Nirvapa: Shiny black with intense golden lustre, fine dispersed particles

Yield and Changes:

· Weight Loss: The initial 1000 g of raw mica yielded 902 g after purification, representing a 9.8% loss

· Texture Change: The mica became more brittle and finer, with reduced impurities

· Absorption: During the process, the mica absorbed some of the Triphala constituents, as evidenced by weight gain in intermediate steps

3.2 Dhanyabhraka (Grain Treatment)

Principle: A mechanical process to divide pure Abhraka into fine particles using grains (Dhanya) .

Procedure :

· Materials: Purified Abhraka (902 g) is mixed with 1/4th part of Dhanya (paddy seeds)

· Preparation: The mixture is placed in a piece of blanket or rag and tied to form a Potali (bundle)

· Soaking: The bundle is dipped into water for 24 hours

· Pressing: After soaking, the bundle is pressed gently with the palms

· Collection: The finest blackish particles of Abhraka are seen floating in the water and are collected

· Drying: The collected particles are dried in Bhanuputa (sunlight)

Yield and Changes:

· Weight Loss: 23.83% loss

· pH Reduction: The process resulted in effective leaching and pH reduction

· Significance: This unique process is prescribed exclusively for mica in Rasa Shastra

3.3 Marana (Incineration)

Principle: Subjecting the processed mica to controlled high-temperature incineration to convert it into a non-toxic, bioavailable form.

General Procedure:

· The Dhanyabhraka is taken in a mortar and impregnated with specific liquid media

· Small cakes (Chakrikas) are formed and dried

· The cakes are placed in an earthen vessel and subjected to Puta (incineration)

· The process is repeated for multiple cycles

Classical Variations:

Method 1 (from Rasa Tarangini):

· First Cycle: Dhanyabhraka is impregnated with the juice of Kasaundi (Cassia occidentalis) and subjected to 10 Gaja Puta (a specific type of incineration using an earthen pit and cow dung cakes)

· Second Cycle: The resulting material is impregnated with the milk of Arka (Calotropis procera) and subjected to another 10 Gaja Puta

· Final Product: The process yields a fine, brick-red, lustreless Bhasma

Method 2 (Alternative):

· The Dhanyabhraka is processed with Triphala Kwatha and subjected to Puta with a specific number of cow dung cakes

· The process may be repeated 30 to 1000 times depending on the desired potency

Gajaputa: This specific incineration setup requires construction of a pit in the ground 2 feet square and 2 feet deep. The pit is filled with dry cow dung cakes, and the sealed vessel containing the medicine is placed in between the cakes. The dung cakes are set to flame and the medicine is allowed to cook until the cakes burn out .

1000 Puta (Sahastraputi) Bhasma:

· The purified Abhraka is processed in Ark Ksheer (milky latex) or Ark Patra Swaras (leaf juice of Calotropis) and rolled into cakes

· The dried cakes are transferred to an earthen vessel and given a Gajaputa

· This process is repeated 1000 times to obtain the Sahastraputi Abhrak Bhasma

Observations During Marana :

· Weight Loss: 14.7% loss

· Colour Change: Transition from blackish red to dull red

· Texture: The final Bhasma becomes non-lustrous and fine

3.4 Amritikarana (Detoxification and Enhancement)

Principle: This process eliminates any remaining Dosha (impurities/toxins) from the Bhasma and enhances its therapeutic properties.

Procedure :

· Materials: 10 parts of Abhrak Bhasma, 16 parts of Triphala Kashaya (decoction), and 8 parts of cow ghee

· Heating: The mixture is placed in an iron pan and subjected to heating

· Drying: When the mixture is completely dried, it is considered fit for internal use

· Outcome: Enhanced stability and reduced toxicity

3.5 Lohitikarana (Colour Conversion)

Principle: A process to impart a specific colour to the Bhasma to enhance its therapeutic potential.

Procedure :

· The processed Bhasma is subjected to Bhavana (trituration) with specific liquid media

· The process imparts a red tinge to the Bhasma

· Outcome: Improved therapeutic potential

4. Quality Assessment (Bhasma Pariksha)

After preparation, the Bhasma must pass a series of classical tests to confirm its proper incineration and safety.

4.1 Classical Bhasma Pariksha

The following tests are universally applied to all Bhasmas:

· Rekhapurnata: The fine powder should enter the furrows of the fingers when rubbed, indicating fineness of particle size

· Varitara: The Bhasma should float on the surface of still water, indicating proper incineration and nano-particle formation

· Unama: The Bhasma should remain floating even when a rice grain is placed on it

· Nirdhuma: The Bhasma should not emit any fumes when exposed to fire

· Niswadu: The Bhasma should not possess any taste

· Nishchandrata: The Bhasma should be free from any residual shining particles of the original metal

· Apunarbhava: The Bhasma should not regain its original metallic luster when heated

· Niruttha: When the Bhasma is treated with a silver coin, the weight of the coin should not increase

4.2 Quality Parameters from Analytical Studies

Particle Size:

· SEM analysis: 92.3 nm

· TEM analysis: 50 nm to 1 micrometre

· XRD analysis: 62 nm

· These studies confirm that Abhrak Bhasma is a nano-crystalline material, which enhances its bioavailability and biological activity

Elemental Composition:

Analysis of standardized Abhrak Bhasma reveals the following elemental profile :

· Silicon: 14.18%

· Aluminum: 7.58%

· Magnesium: 5.03%

· Iron: 12.64%

· Potassium: 8.36%

· Sodium: 1.39%

· Calcium: 3.64%

· Oxygen: 35.69%

· Carbon: 9.57%

· Titanium: 1.16%

· Phosphorus: 0.76%

· Trace elements: Manganese, Chromium, Lithium, Barium, Rubidium, Cesium

Mineral Phase:

XRD studies confirm the presence of KMg₃(Si₃Al)O₁₀(OH)₂ in the Bhasma, indicating that the final product is a complex aluminosilicate compound rather than elemental mica .

Physicochemical Parameters:

· Loss on Drying: Low moisture content

· Total Ash: High ash value indicating inorganic nature

· Acid Insoluble Ash: Low, indicating minimal contamination

· Water Soluble Ash: High, indicating solubility of active components

· pH: The Bhasma exhibits a slightly alkaline nature

4.3 Significance of Herbo-Mineral Complex

The presence of carbon (9.57%) in the final Bhasma confirms that it is a herbo-mineral compound, where the inorganic mineral matrix is associated with organic materials from the herbal processing media. This complexation contributes to its therapeutic effects and influences the bioavailability and toxicity profile of the inorganic constituents .

5. Pharmacological Properties and Therapeutic Applications

5.1 Antioxidant and Rasayana Activity

Abhrak Bhasma exhibits potent antioxidant properties that form the basis of its Rasayana (rejuvenative) action. Numerous studies have confirmed its antioxidant activity through various in vitro assays including DPPH, FRAP, and ABTS .

Mechanisms:

· Free Radical Scavenging: Direct neutralization of reactive oxygen species

· Enzyme Modulation: Enhancement of endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH)

· Lipid Peroxidation Inhibition: Significant reduction in malondialdehyde (MDA) levels, a marker of oxidative stress, in animal models of stress and ageing

This antioxidant action is considered the primary mechanism underlying its broad-spectrum therapeutic efficacy in chronic diseases associated with oxidative damage.

5.2 Immunomodulatory Activity

Abhrak Bhasma has been demonstrated to regulate both humoral and cell-mediated immunity .

Mechanisms:

· Macrophage Activation: Boosts the activity of macrophages, enhancing their phagocytic capacity

· Antibody Production: Raises antibody levels in vaccinated animals

· Cytokine Modulation: Regulates inflammatory cytokines

· Tissue Nourishment: Acts as a Dhatu Pushtikara (tissue nourisher) and restores Ojas (vital essence), which is conceptually equivalent to enhancing immune competence

5.3 Hepatoprotective Activity

Abhrak Bhasma has demonstrated significant protective effects against liver damage induced by various hepatotoxins.

Evidence:

· Carbon Tetrachloride (CCl₄) Induced Hepatotoxicity: Considerable protection against CCl₄-induced liver damage

· Paracetamol Induced Hepatotoxicity: Protective effects against paracetamol-induced hepatic injury

· Ethanol Induced Hepatotoxicity: Protection against alcohol-induced liver damage

Mechanisms:

· Reduction in elevated liver enzymes including SGOT, SGPT, and ALP

· Decrease in bilirubin levels

· Histopathological improvement in liver architecture

· Antioxidant-mediated protection

5.4 Antidiabetic Activity (Prameha)

Abhrak Bhasma has been validated for its anti-diabetic properties through various animal studies .

Evidence:

· Blood Glucose Reduction: Significant decrease in blood glucose levels in streptozotocin (STZ)-induced diabetic rats

· HbA1c Reduction: Decrease in glycosylated haemoglobin levels

· Lipid Profile Improvement: Enhancement of lipid profile parameters

· Body Weight: Improvement in body weight, indicating metabolic recovery

Mechanism :

· Insulin Secretion: Induces insulin secretion from pancreatic beta cells, acting as a cellular regenerator

· Beta Cell Regeneration: Helps in the regeneration of pancreatic beta cells

· Antioxidant Activity: Reduces oxidative stress associated with diabetes

5.5 Anti-Anemic Activity (Pandu)

Research has validated the haematinic characteristics of Abhrak Bhasma .

Evidence:

· Haemoglobin Elevation: Substantial increase in haemoglobin levels

· RBC Count Increase: Enhancement of red blood cell count

· Serum Iron Increase: Elevation of serum iron concentrations

Models Studied:

· Phenylhydrazine-induced haemolytic anaemia

· Nutritional anaemia models

5.6 Anticancer Activity

Abhrak Bhasma has emerged as a promising candidate for integrative oncology, with its traditional use in conditions similar to breast cancer (Stanarbuda) being supported by modern research .

Rationale:

The traditional Ayurvedic rationale for using Abhrak Bhasma in breast cancer is based on its Dhatu-Pushtikara (tissue-nourishing), Rasayana (rejuvenating), and Tridosha-balancing properties. Breast cancer (Stanarbuda) is attributed to a Tridosha imbalance causing abnormal Mamsa Dhatu (muscle tissue proliferation). The Lekhana (scraping) Karma of Abhrak Bhasma is traditionally thought to clear this abnormal tissue proliferation .

In Vitro Evidence :

· Cytotoxicity: Exhibits dose-dependent cytotoxicity against MCF-7 human breast cancer cells

· Apoptosis Induction: Triggers programmed cell death in cancer cells

· Immunomodulation: Reduces nitric oxide production in the tumor microenvironment

· Teratoma Inhibition: Inhibits teratoma formation in different cell lines

In Vivo Evidence :

· DNA Repair Enhancement: Enhanced DNA base excision repair capacity

· Genotoxicity Reduction: Non-genotoxic, with reduced genotoxicity in animal models

· Chemopreventive Responses: Chemopreventive effects

· Immunostimulatory Effects: Modulation of immune responses in the tumor microenvironment

Current Status:

The available evidence on Abhrak Bhasma in cancer treatment is currently preclinical (Level 5 evidence) and hypothesis-generating only. To date, no randomized controlled trials or cohort studies (Levels 1-3) on its safety and efficacy as an adjunct in breast cancer treatment have been published .

5.7 Nephroprotective and Other Activities

Abhrak Bhasma also demonstrates:

· Nephroprotective Effects: Protection against kidney damage

· Anti-inflammatory Activity: Significant anti-inflammatory effects

· Adaptogenic Activity: Enhances stress adaptation

· Nootropic Activity: Enhances cognitive function and intellect

· Respiratory Benefits: Demonstrated efficacy in Tamaka Shwasa (bronchial asthma) with improvements in dyspnoea, cough, wheezing, and pulmonary function tests (FEV1, PEFR)

6. Clinical Applications and Emerging Evidence

6.1 Respiratory Disorders

Indication: Tamaka Shwasa (Bronchial Asthma)

· Evidence: Randomized controlled trials have demonstrated that formulations containing Abhrak Bhasma result in substantial enhancement of symptoms (dyspnoea, cough, wheezing) and pulmonary function tests (FEV1, PEFR) compared to placebo

6.2 Diabetes Mellitus

Indication: Prameha (Diabetes)

· Evidence: Open-label clinical studies indicate improved glycaemic control (decrease in fasting and postprandial blood glucose levels) when Abhrak Bhasma is used alongside standard therapy

6.3 Anemia

Indication: Pandu (Iron-Deficiency Anemia)

· Evidence: Studies on iron-deficiency anemia have shown that Abhrak Bhasma supplementation increases haemoglobin levels effectively

6.4 General Debility and Hepatitis

Indication: Chronic debility and liver disorders

· Evidence: Case series have documented its benefits in enhancing appetite, weight, and strength in debilitated patients, as well as in normalising liver enzymes in viral hepatitis

6.5 Integrative Oncology

Indication: Breast Cancer (as an adjunct)

· Current Status: Preclinical data suggest potential, but rigorous clinical trials are needed

· Future Direction: Clinical translation requires large-scale, multi-centre, randomized, double-blind, placebo-controlled trials

7. Dosage and Administration

7.1 Standard Therapeutic Dose

The standard therapeutic dose of Abhrak Bhasma depends on the preparation and the condition being treated.

General Range:

· Daily Dose: 120 mg to 360 mg per day, typically taken in divided doses

· For Specific Conditions: Dosage is determined by the physician based on the patient's constitution and disease

7.2 Anupana (Vehicle)

The Bhasma is commonly administered with specific Anupanas (vehicles) to enhance its absorption and action:

· Honey

· Cow's ghee

· Warm milk

· Specific decoctions as prescribed

7.3 Formulations

Abhrak Bhasma is a single-ingredient incinerated mineral but is also a key component in various compound formulations:

· Sahastraputi Abhrak Bhasma: Prepared with 1000 incinerations, considered the most potent

· Panchamrut Parpati: A compound formulation containing Abhrak Bhasma as a key ingredient

· Various other Rasayana preparations

8. Safety and Toxicology

8.1 The Safety Paradox

The paramount concern regarding herbo-mineral preparations is their safety. Extensive research on properly prepared Abhrak Bhasma has yielded reassuring results .

Key Finding: The metals in Abhrak Bhasma are not free ions but rather stable, complex oxide and silicate compounds. This chemical bonding, which occurs during the calcination process, renders them non-bioavailable and non-toxic. They do not dissolve in gastric juice and are excreted without being absorbed into the body. This distinguishes a well-made Bhasma from raw metal poisoning .

8.2 Acute and Sub-Acute Toxicity

Acute Toxicity :

· LD50: > 2000 mg/kg body weight in rats, classifying it as non-toxic per OECD guidelines

· NOAEL (No Observed Adverse Effect Level): No toxicity observed up to 2000 mg/kg orally for 2 weeks

Sub-Acute Toxicity :

· NOAEL: > 1000 mg/kg/day, as per OECD 407 guidelines for 28-day studies in Sprague-Dawley rats

· Observations: No significant changes in body weight, organ weight, haematological parameters, or biochemical parameters

· Histopathology: No significant histological changes in essential organs such as liver, kidney, and brain

8.3 Heavy Metal Safety

Elemental Profile :

· Mercury: Absent in properly prepared Abhrak Bhasma

· Lead: Below detectable limits or within safe limits

· Arsenic: Within safe limits

· Aluminum: Present as part of the stable aluminosilicate matrix, not as free toxic ions

Genotoxicity :

· Non-Genotoxic: Abhrak Bhasma is non-genotoxic in Swiss albino rats at doses of 120 mg/kg or 360 mg/kg body weight

· DNA Repair: Enhances DNA repair capacity, suggesting a protective effect

8.4 Cautions

Special Populations:

· Pregnancy and Lactation: Should be used only under strict medical supervision

· Children: Dosage must be carefully adjusted

Quality Assurance:

The most critical safety factor is the use of properly prepared Abhrak Bhasma that has passed all the classical quality tests (Nishchandrata, Varitara, etc.). Improperly prepared Bhasma with residual metallic luster is toxic. Therefore, it must only be procured from reputable manufacturers and prescribed by qualified practitioners.

9. Professional Supervision and Scope of Use

Abhrak Bhasma is a potent herbometallic drug whose preparation and administration require the direct supervision of a qualified Vaidya with expertise in Rasa Shastra. The physician will:

1. Prakriti Assessment (Constitutional Type): Determine the patient's constitution to assess the suitability and the most appropriate Anupana

2. Vikriti Assessment (Current Imbalance): Identify the specific condition and determine the appropriate therapeutic formulation, dose, and duration

3. Agni Assessment (Digestive Strength): Ensure the patient's digestive capacity is adequate to metabolize the Bhasma

4. Quality Control: Ensure the Bhasma being administered has been prepared according to classical standards and has passed all the required quality tests

5. Monitoring: Closely monitor the patient for any adverse effects and manage them promptly

Abhrak Bhasma is not a standalone cure for any serious disease. Its role is as a powerful Rasayana and systemic modulator that supports the body's natural healing mechanisms. It must be used within a properly supervised, multimodal treatment framework that includes dietary modifications, lifestyle changes, and other Ayurvedic or conventional medical interventions. It should not be used to delay or replace evidence-based medical treatment when such treatment is indicated.

-x-x-

This monograph was prepared by synthesizing classical Ayurvedic principles from Rasa Tarangini, Rasaratna Samuchchaya, and other primary texts with peer-reviewed modern research, including systematic reviews (Singh et al., REDVET, 2025), pharmaceutical studies on preparation methodology (Baletiya et al., AYUSHDHARA, 2025), anticancer perspectives (Soman Pillai & Karavettekudy, Frontiers in Pharmacology, 2025), and various preclinical studies on antioxidant, immunomodulatory, hepatoprotective, antidiabetic, and safety profiles.